lamivudine has been researched along with Esophageal Varices in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, SH; Bae, SH; Cheong, JY; Han, KH; Jang, BK; Jeong, SW; Kim, BI; Kim, DJ; Kim, JK; Kim, MY; Kim, SG; Kim, TY; Kwon, JH; Kwon, SY; Lee, HW; Lee, JW; Myoung, S; Park, JY; Seo, YS; Tak, WY; Yim, HJ; Yoon, KT | 1 |
Casazza, G; Colombo, M; de Franchis, R; Facchetti, F; Fraquelli, M; Iavarone, M; Invernizzi, F; Jovani, M; Lampertico, P; Loglio, A; Mangia, G; Primignani, M; ViganĂ², M | 1 |
1 trial(s) available for lamivudine and Esophageal Varices
Article | Year |
---|---|
Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Splenomegaly; Thrombocytopenia; Viral Load | 2019 |
1 other study(ies) available for lamivudine and Esophageal Varices
Article | Year |
---|---|
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study.
Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Elasticity Imaging Techniques; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Follow-Up Studies; Forecasting; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Italy; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Nucleosides; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Survival Rate; Tenofovir | 2015 |